These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29790022)

  • 1. Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016.
    Uusküla A; Pisarev H; Kurvits K; Laius O; Laanpere M; Uusküla M
    Drugs Real World Outcomes; 2018 Jun; 5(2):129-136. PubMed ID: 29790022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with Pregnancy Prevention Recommendations for Isotretinoin Following the Amendment of the European Union Pregnancy Prevention Program: A Repeat Study in Estonia.
    Ivask M; Kurvits K; Uusküla M; Juppo A; Laius O; Siven M
    Drugs Real World Outcomes; 2024 Mar; 11(1):91-98. PubMed ID: 37462893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isotretinoin: compliance with recommendations in childbearing women].
    Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
    Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with pregnancy prevention measures during isotretinoin therapy.
    Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
    J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
    Pinheiro SP; Kang EM; Kim CY; Governale LA; Zhou EH; Hammad TA
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1251-7. PubMed ID: 23913625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.
    Autret-Leca E; Kreft-Jais C; Elefant E; Cissoko H; Darrouzain F; Grimaldi-Bensouda L; Attia S; Jonville-Béra AP
    Drug Saf; 2010 Aug; 33(8):659-65. PubMed ID: 20635824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020.
    Albogami Y; Almadani O; Almohareb SN; Alshehri S; Alkhaibari A; Anzan M; Alsharif A; Alhossan A; Alrwisan A
    Ther Adv Drug Saf; 2024; 15():20420986241272822. PubMed ID: 39290803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
    AlGhamdi KM; Khurram H; Asiri YA; Mandil A
    Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
    Boucher N; Beaulac-Baillargeon L
    Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with the pregnancy prevention program among women initiating isotretinoin treatment between 2014 and 2021: A nationwide cohort study on the French Health Data System (SNDS).
    Havet A; Bouvard C; Moskal A; Chanelière M; Massardier J; Lebrun-Vignes B; Jonville-Bera AP; Payet C; Viprey M
    J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38764351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of isotretinoin among girls and women of childbearing age and occurrence of isotretinoin-exposed pregnancies in Germany: A population-based study.
    Reinold J; Kollhorst B; Wentzell N; Platzbecker K; Haug U
    PLoS Med; 2024 Jan; 21(1):e1004339. PubMed ID: 38271295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate.
    Pastuszak A; Koren G; Rieder MJ
    Reprod Toxicol; 1994; 8(1):63-8. PubMed ID: 8186626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of isotretinoin use and Saudi FDA pregnancy prevention program in Riyadh, Saudi Arabia: A cross-sectional study among female patients.
    Ibrahim AAM; Alshatri AA; Alsuwaidan S; Almutairi L; Aljasser N; Mahmoud MA; Alaseeri A; Almonysir A; Alotaibi B; Alrasheed B; Alfawaz M
    Saudi Pharm J; 2021 Jun; 29(6):527-532. PubMed ID: 34194259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study.
    Crijns HJ; van Rein N; Gispen-de Wied CC; Straus SM; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1060-6. PubMed ID: 22228673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.